Repeatability of AI-quantified incidental findings on lung cancer screening CT scans in the NELSON trial - Scorecard - MDSpire

Repeatability of AI-quantified incidental findings on lung cancer screening CT scans in the NELSON trial

  • By

  • Stijn Bunk

  • Thijs Bruins Slot

  • Edwin Bennink

  • Grigory Sidorenkov

  • Nils van der Velden

  • Niels Schurink

  • Félix Lades

  • Markus Sebald

  • Marjolein A. Heuvelmans

  • Hester A. Gietema

  • Joachim G. Aerts

  • Geertruida H. de Bock

  • Cornelia Schaefer-Prokop

  • Pim A. de Jong

  • Rozemarijn Vliegenthart

  • Firdaus A. A. Mohamed Hoesein

  • June 17, 2026

  • 0 min

Share

Clinical Scorecard: Consistency of AI-Detected Incidental Findings in Lung Cancer Screening CT Scans from the NELSON Study

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationIndividuals aged 50–75 years with significant smoking history
Care Setting

Key Highlights

  • Study focuses on repeatability and agreement of AI measurements.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

        • I
        • n
        • c
        • r
        • e
        • a
        • s
        • e
        • d
        • w
        • o
        • r
        • k
        • l
        • o
        • a
        • d
        • f
        • o
        • r
        • r
        • a
        • d
        • i
        • o
        • l
        • o
        • g
        • i
        • s
        • t
        • s
        • m
        • a
        • y
        • l
        • e
        • a
        • d
        • t
        • o
        • i
        • n
        • t
        • e
        • r
        • p
        • r
        • e
        • t
        • i
        • v
        • e
        • e
        • r
        • r
        • o
        • r
        • s
        • d
        • u
        • e
        • t
        • o
        • f
        • a
        • t
        • i
        • g
        • u
        • e
        • a
        • n
        • d
        • o
        • v
        • e
        • r
        • s
        • i
        • g
        • h
        • t
        • .

        Patient & Prescribing Data

        AI can enhance the identification and management of incidental findings, potentially improving patient outcomes.

        Clinical Best Practices

        • Ensure accurate segmentation of AI-generated measurements
        • Use standardized imaging protocols for consistency
        • Validate AI measurements against manual assessments
        • Continuously validate AI tools in clinical settings.

        Related Resources & Content

        Original Source(s)

        Repeatability of AI-quantified incidental findings on lung cancer screening CT scans in the NELSON trial

        • by Stijn Bunk, Thijs Bruins Slot, Edwin Bennink, Grigory Sidorenkov, Nils van der Velden, Niels Schurink, Félix Lades, Markus Sebald, Marjolein A. Heuvelmans, Hester A. Gietema, Joachim G. Aerts, Geertruida H. de Bock, Cornelia Schaefer-Prokop, Pim A. de Jong, Rozemarijn Vliegenthart, Firdaus A. A. Mohamed Hoesein

        • June 17, 2026

        Related Content

        Who Decides When a Doctor Steps Back?

        Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

        When to Treat First in Metastatic NSCLC?

        Real-world data show flexible sequencing of immunotherapy and local radical treatment can achieve durable survival in selected patients with synchronous oligometastatic NSCLC

        Quality over quantity: biopsy-anchored CT radiogenomics models outperform all-lesion training in a multi-tumour cohort despite a smaller sample size